Cancer cells can now turn back to normal cells, thanks to South Korean Scientists.

The sources describe an important but early-stage research finding associated with KAIST researchers. The reported methods, described variously as BENEIN or REVERT, use computational modeling and targeted genetic changes to influence cancer-cell behavior.

The evidence supports these narrower conclusions:

• Experiments involving colon-cancer cell lines reportedly caused cells to grow more slowly, become less aggressive, and display characteristics closer to healthy intestinal cells.
• The work is based primarily on laboratory experiments and computational analysis; some reporting also mentions animal-model testing, but the supplied summaries do not establish successful human clinical treatment.
• The phrase “turn cancer cells back to normal” overstates the finding. “Normal-like” or “reprogrammed” is more accurate than fully restored normal human tissue.
• The claim also generalizes from a specific cancer type, primarily colorectal/colon cancer, to cancer as a whole. Different cancers have distinct mutations, cell environments, and treatment challenges.
• No supplied source demonstrates regulatory approval, human clinical-trial efficacy, long-term safety, prevention of recurrence, or a currently available therapy.

The publication timing is also relevant. refers to KAIST work published in December 2024, while appears to be later coverage and reports on the reversion-switch research. Later media attention does not by itself establish that the technique has progressed into clinical care.timesofindia.indiatimes.comtimesofindia.indiatimes.comCancer: A game-changer in cancer research? South Korean scientists reprogram...koreabiomed.comkoreabiomed.comKorean researchers find ‘reversion switch’ that turns cancer cells back to...+1 more